| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
47,651 |
43,241 |
$3.09M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,156 |
15,946 |
$1.22M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
8,103 |
8,084 |
$507K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,534 |
3,254 |
$97K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
979 |
973 |
$88K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,708 |
2,631 |
$76K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,695 |
5,362 |
$55K |
| 86328 |
|
1,503 |
1,430 |
$50K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,795 |
1,881 |
$45K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,832 |
2,776 |
$35K |
| 99000 |
|
4,691 |
4,297 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,237 |
1,199 |
$7K |
| 81002 |
|
2,057 |
2,019 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,066 |
2,016 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,689 |
1,588 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
158 |
157 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,086 |
2,885 |
$2K |
| 81025 |
|
90 |
90 |
$570.40 |
| 73130 |
|
12 |
12 |
$263.88 |
| S9083 |
Global fee urgent care centers |
126 |
114 |
$95.00 |
| 99051 |
|
203 |
190 |
$0.00 |